TrialAnnals of oncology : official journal of the European Society for Medical Oncology2014

A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma.

B Rini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.